Venture Capital · Toronto (Canada), Montr茅al (Canada), Vancouver (Canada), Boston (United States) · Founded 2007
Lumira Ventures is a leading Canadian life sciences venture capital firm investing in and helping to create value in transformative life sciences companies. They focus on biotech, medtech, and healthcare companies transforming global healthcare through innovation, aiming for exceptional returns while delivering impact to patients.
Seed, Series A, Series B
BioTech, MedTech
Endotronix, OpSens Medical, Bardy, Engage Therapeutics, Pharmasset, MAKO Surgical, Aurinia Pharmaceuticals, Zymeworks, G1 Therapeutics, Ception Therapeutics, KAI Pharmaceuticals, ESSA Pharmaceuticals, Forbius, Alveolus, Corus Pharmaceuticals, Depomed, ISTA Pharmaceuticals, Guava Technologies, Morphotek, Resonant Medical, Spinal Kinetics, U-Systems, Think Research, Alpha-9, AmacaThera, Antiva Biosciences, Arclight Therapeutics, Axonis, BioTheryX, Bright Angel Therapeutics, Cadence Neuroscience, Cardiac Dimensions, Congruence Therapeutics, Corvia Medical, COUR Pharmaceuticals, Cyrano Therapeutics, DAMONA Pharmaceuticals, DEKA Biosciences, Edesa Biotech, Endogenex, enGene, Exact Imaging, Fusion Pharmaceuticals, GenEp, Histosonics, Iterion Therapeutic, Kalgene, Kisoji, Medexus Pharmaceuticals, Nocion Therapeutics, Notch Therapeutics, Specific Biologics, SpectraWAVE, Thryv Therapeutics, Transposon Therapeutics, X4 Pharmaceuticals, XyloCor Therapeutics